Format

Send to

Choose Destination
See comment in PubMed Commons below
J Am Acad Dermatol. 2017 Jun;76(6):1213-1217. doi: 10.1016/j.jaad.2017.01.031. Epub 2017 Mar 30.

Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and Alternative Payment Models in dermatology.

Author information

1
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: john.barbieri@uphs.upenn.edu.
2
Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
3
Yale University, New Haven, Connecticut; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
4
Baylor College of Medicine, Houston, Texas.
5
Yale University, New Haven, Connecticut; Department of Public Health (Health Policy), Economics, and Management, Yale University, New Haven, Connecticut.
6
Department of Dermatology, University of Iowa (Carver) College of Medicine, Iowa City, Iowa.

Abstract

With the introduction of the Medicare Access and Children's Health Insurance Program Reauthorization Act, clinicians who are not eligible for an exemption must choose to participate in 1 of 2 new reimbursement models: the Merit-based Incentive Payment System or Alternative Payment Models (APMs). Although most dermatologists are expected to default into the Merit-based Incentive Payment System, some may have an interest in exploring APMs, which have associated financial incentives. However, for dermatologists interested in the APM pathway, there are currently no options other than joining a qualifying Accountable Care Organization, which make up only a small subset of Accountable Care Organizations overall. As a result, additional APMs relevant to dermatologists are needed to allow those interested in the APMs to explore this pathway. Fortunately, the Medicare Access and Children's Health Insurance Program Reauthorization Act establishes a process for new APMs to be approved and the creation of bundled payments for skin diseases may represent an opportunity to increase the number of APMs available to dermatologists. In this article, we will provide a detailed review of APMs under the Medicare Access and Children's Health Insurance Program Reauthorization Act and discuss the development and introduction of APMs as they pertain to dermatology.

KEYWORDS:

Alternative Payment Models; Medicare Access and Children's Health Insurance Program Reauthorization Act; Merit-based Incentive Payment System; bundled payment; dermatology; health care reform; payment reform

PMID:
28365040
DOI:
10.1016/j.jaad.2017.01.031
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center